Rate and predictors of successful antitumor necrosis factor deescalation after dose intensification in inflammatory bowel disease patients: a real-world Greek–Turkish collaborative study
Year: 2025
Type: article
Study design: Observational Study
Authors: Nikos Viazis, Murat Toruner, Vasilios Papastergiou, Konstantinos Mousourakis, Angeliki Christidou, Maria Tzouvala, Eirini Zacharopoulou, Maria Palatianou, Georgios Theocharis, Georgios Geramoutsos, Angeliki Theodoropoulou, Konstantinos Karmiris, Magdalini Velegraki, Aykut Ferhat Çelik, Atilla Akpinar, Evanthia Zampeli, Evgenia Papathanasiou, Nalan Gulsen Unal, Andreas Kapsoritakis, Konstantinos Argyriou, Dimitrios Christodoulou, Konstantinos Katsanos, Fotios Fousekis, Tarkan Karakan, Ioannis E. Koutroubakis, Ioannis Drygiannakis, Olga Giouleme, Maria Kalogirou, Evangelina Vlachou, Christos Liatsos, Nikolaos Kyriakos, Eftychia Tsironi, Panagiotis Markopoulos, George Bamias, Konstantina Chalakatevaki, Georgia Tsiolakidou, Charikleia Lamouri, George Tribonias, Konstantina Dimopoulou, Panagiotis Kasapidis, Konstantina Paraskeva, Pelin Telli, Filiz Akyuz
Institutions: Evangelismos Hospital, Ankara University, General Hospital of Nikea, University of Patras, The General Hospital of Heraklion "Venizeleio-Pananio", Istanbul University-Cerrahpaşa, Istanbul University, Alexandra Hospital, Ege University, University Hospital of Larissa, University Hospital of Ioannina, Gazi University, University Hospital of Heraklion, Ippokrateio General Hospital of Thessaloniki, 401 General Military Hospital of Athens, Metaxa Hospital, Sotiria General Hospital
Language: English
Topic: Inflammatory Bowel Disease
Subfield: Genetics
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W4417035693